Analyst Ratings for Atara Biotherapeutics (ATRA)
ATRA Rating Summary
ATRA Price Target Summary
- Highest: $18.00 (Mizuho)
- Lowest: $6.00 (Canaccord)
- Average: $12.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$12.00 (+132.1%)
* Over Last 12-Mos
Rating Score: 2.7 / 10
Percentile Rank: 22%
Avg. $ Target:
$12.00 (+132.1%)
* Over Last 12-Mos
Rating Score: 2.7 / 10
Percentile Rank: 22%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/13/2026 | Canaccord | John Newman | Downgrade | Hold (Buy) |
6.00 (25.00) |
5.88 (5.17) |
-12.07% | Details |
| 1/21/2025 | Rodman & Renshaw | Tony Butler | Downgrade | Neutral (Buy) |
7.00 (25.00) |
6.57 (5.17) |
-21.31% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
